Showing results (51-60 of 71) with videos related to
Sort By:
Pageof 8
European Journal of Radiology|October 13, 2020
Preoperative prediction of peritoneal metastasis in colorectal cancer using a clinical-radiomics modelMenglei Li, Kai Sun, Weixing Dai, et al.JAMA Oncology|April 20, 2023
Early Detection of Molecular Residual Disease and Risk Stratification for Stage I to III Colorectal Cancer via Circulating Tumor DNA MethylationShaobo Mo, Li Ye, Dongyang Wang, et al.International Journal of Radiation Oncology, Biology, Physics|February 5, 2021
CBP/P300 Inhibitors Mitigate Radiation-Induced GI Syndrome by Promoting Intestinal Stem Cell-Mediated Crypt RegenerationXinxin Rao, Peiyuan Tang, Yuanchuang Li, et al.Journal of Hematology & Oncology|October 27, 2021
Multi-dimensional fragmentomic assay for ultrasensitive early detection of colorectal advanced adenoma and adenocarcinomaXiaoji Ma, Yikuan Chen, Wanxiangfu Tang, et al.Frontiers in Oncology|March 15, 2021
Fecal Multidimensional Assay for Non-Invasive Detection of Colorectal Cancer: Fecal Immunochemical Test, Stool DNA Mutation, Methylation, and Intestinal Bacteria AnalysisShaobo Mo, Hui Wang, Lingyu Han, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 26, 2026
Functional precision oncology platform of BRAFV600E-mutated colorectal cancer organoids predicts therapy response and reveals RNF43-mediated immunogenicityShaobo Mo, Wenqin Luo, Jiajun Yang, et al.Journal of Hematology & Oncology|September 5, 2020
Modeling tumor development and metastasis using paired organoids derived from patients with colorectal cancer liver metastasesHe Li, Weixing Dai, Xi Xia, et al.Journal of Translational Medicine|May 19, 2022
Bulk and single-cell transcriptome profiling reveal necroptosis-based molecular classification, tumor microenvironment infiltration characterization, and prognosis prediction in colorectal cancerWenqin Luo, Wenqiang Xiang, Lu Gan, et al.Experimental Hematology & Oncology|April 5, 2026
Multi-omics analysis of patient-derived organoids reveals that E3 ligase COP1 promotes liver metastasis and oxaliplatin resistance in colorectal cancer through LUZP1 degradation and MYL9 phosphorylationRuijia Zhang, Wenqin Luo, Qikai Zhou, et al.Signal Transduction and Targeted Therapy|September 3, 2020
GLUT3 induced by AMPK/CREB1 axis is key for withstanding energy stress and augments the efficacy of current colorectal cancer therapiesWeixing Dai, Ye Xu, Shaobo Mo, et al.Pageof 8